2007

1. Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis

   Leukemia, Vol. 21, Núm. 1, pp. 143-150

2. Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients

   Biology of Blood and Marrow Transplantation, Vol. 13, Núm. 12, pp. 1448-1454